Cargando…

Chronic graft-versus-host disease exacerbation after SARS-CoV-2 vaccination

Detalles Bibliográficos
Autores principales:	Trunk, Andrew D., Shewan, Samuel K., Lee, Catherine J., Parker, Charles J., Couriel, Daniel R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8751659/ https://www.ncbi.nlm.nih.gov/pubmed/35017662 http://dx.doi.org/10.1038/s41409-021-01543-z

Ejemplares similares

Chronic Graft-Versus-Host Disease (cGVHD) Exacerbation after Sars-Cov-2 Covid Vaccination
por: Trunk, Andrew D., et al.
Publicado: (2021)

A Rare Presentation of Acute on Chronic Graft Versus Host Disease
por: Khurana, Surbhi, et al.
Publicado: (2022)

Cutaneous Chronic Graft versus Host Disease Mimicking Verruca Vulgaris
por: Jagadeesan, Soumya, et al.
Publicado: (2023)

Multiple spider angiomas in a patient with chronic hepatic graft-versus-host disease
por: Gu, Ying, et al.
Publicado: (2020)

Combination of bortezomib plus ruxolitinib in steroid-refractory chronic graft-versus-host disease
por: Kaloyannidis, Panayotis, et al.
Publicado: (2018)

Covid-19-vaccine: Exacerbation of chronic graft versus host disease: 9 case reports
Publicado: (2022)

Regenerating islet-derived protein 3-α is a prognostic biomarker for gastrointestinal chronic graft-versus-host disease
por: DePriest, Brittany Paige, et al.
Publicado: (2022)

Therapeutic efficacy of azathioprine in addition to prednisone-based regimens as first-line chronic graft-versus-host disease treatment
por: Uhm, Jieun, et al.
Publicado: (2017)

Immunotherapy responsive SARS-CoV-2 infection exacerbating opsoclonus myoclonus syndrome
por: Wiegand, Sarah E., et al.
Publicado: (2021)

Transfusion Associated Graft Versus Host Disease
por: Naveen, Kikkeri Narayanshetty, et al.
Publicado: (2015)

Practice patterns in chronic graft-versus-host disease patient management and patient reported outcome measures across the EBMT allogeneic transplantation network
por: Perovic, Vladimir, et al.
Publicado: (2022)

Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host
por: Choi, Bina, et al.
Publicado: (2020)

Reactivated chronic graft-versus-host disease following SARS-CoV-2 infection
por: Florenzo, Brian, et al.
Publicado: (2022)

Criminology
por: Shewan, G. M.
Publicado: (1896)

Enteric Fever in India
por: Shewan, G. M.
Publicado: (1895)

SARS-CoV-2 vaccines and donor recruitment for FMT
por: Ianiro, Gianluca, et al.
Publicado: (2021)

SARS CoV2 vaccine and aphasia
por: sookaromdee, Pathum, et al.
Publicado: (2021)

Proteomic characterization of Omicron SARS-CoV-2 host response
por: Bao, Jianfeng, et al.
Publicado: (2022)

Advances in graft-versus-host disease prevention strategies: latest updates from the 2022 ASH annual meeting
por: Chen, Yiyin, et al.
Publicado: (2023)

Effect of Vaccination on Household Transmission of SARS-CoV-2 in England
por: Harris, Ross J., et al.
Publicado: (2021)

Acute exacerbation of ocular graft-versus-host disease and anterior uveitis after COVID-19 vaccination
por: Lin, Chen-Yu, et al.
Publicado: (2023)

SARS-CoV-2 infection in a stem cell transplant recipient grafted from a SARS-CoV-2-positive donor
por: Busca, Alessandro, et al.
Publicado: (2022)

SARS-CoV-2 incidence and vaccine escape
por: Thompson, Robin N, et al.
Publicado: (2021)

Effect of Vaccination on Transmission of SARS-CoV-2
por: Shah, Anoop S.V., et al.
Publicado: (2021)

Hemophagocytic lymphohistiocytosis and SARS-CoV-2 vaccination
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Post SARS-CoV-2 vaccination effluvium
por: Luu, Ngoc-Nhi C., et al.
Publicado: (2023)

Safety of SARS-CoV-2 vaccines in patients with chronic myeloid leukemia: a multicenter survey in China
por: Yang, Yunfan, et al.
Publicado: (2022)

Transmissibility of SARS-CoV-2 among fully vaccinated individuals
por: Knol, Mirjam J, et al.
Publicado: (2022)

Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination
por: Widge, Alicia T., et al.
Publicado: (2020)

RT-PCR for SARS-CoV-2: quantitative versus qualitative
por: Han, Mi Seon, et al.
Publicado: (2021)

Unclear conclusions on SARS-CoV-2 elimination versus mitigation
por: Gold, Christian
Publicado: (2021)

Impaired humoral and T cell response to vaccination against SARS-CoV-2 in chronic myeloproliferative neoplasm patients treated with ruxolitinib
por: Harrington, Patrick, et al.
Publicado: (2022)

Could SARS-CoV-2 cause tauopathy?
por: Pratt, James, et al.
Publicado: (2021)

Progress in chronic graft-versus-host disease
por: Martin, Paul J
Publicado: (2011)

Severe clinical relapse in an immunocompromised host with persistent SARS-CoV-2 infection
por: Reuken, Philipp A., et al.
Publicado: (2021)

Safety and immunogenicity of a SARS-CoV-2 inactivated vaccine in patients with chronic hepatitis B virus infection
por: Xiang, Tiandan, et al.
Publicado: (2021)

A strategy for SARS-CoV-2 vaccination in Yemen
por: Nasser, Abdullah, et al.
Publicado: (2021)

Ophthalmologic compromise following SARS-CoV-2 vaccinations
por: Finsterer, Josef
Publicado: (2022)

Comments on COVID-19 Vaccination and Exacerbation of Idiopathic Pulmonary Fibrosis
por: Kang, Tianlun, et al.
Publicado: (2022)

COVID-19 Vaccine in Patients with Exacerbation of Idiopathic Pulmonary Fibrosis
por: Sgalla, Giacomo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rsg0ueftv52hfpbd9ifh072mc8